The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
The accompanying notes are an integral part of
these unaudited consolidated financial statements.
The accompanying notes are an integral part of
these unaudited condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE SIX MONTHS ENDED JUNE 30, 2021 AND 2020
(UNAUDITED)
(Currency expressed in United States Dollars
(“US$”), except for number of shares)
The accompanying unaudited condensed
consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in
the United States (“GAAP”), and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Certain information and note
disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have
been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate
to make the information not misleading.
In the opinion of management, the balance
sheet as of June 30, 2021 which has been derived from unaudited financial statements and these unaudited condensed consolidated financial
statements reflect all normal and recurring adjustments considered necessary to state fairly the results for the periods presented. The
results for the period ended June 30, 2021 are not necessarily indicative of the results to be expected for the entire fiscal year ending
December 31, 2021 or for any future period.
These unaudited condensed consolidated
financial statements and notes thereto should be read in conjunction with the Management’s Discussion and the audited financial
statements and notes thereto included in the Form 10-K for the year ended December 31, 2020.
2.
|
DESCRIPTION OF BUSINESS AND ORGANIZATION
|
United Royale Holdings Corp., formerly
known as Bosy Holdings Corp. (“the Company”, “we”, “us” or “our”) was incorporated in
the State of Nevada on June 23, 2015. We intended to offer planting and cultivation services to land owners in regards to the planting and
cultivation of Aquilaria Subintegra & Aquilaria Sinensis trees. We also intended to provide services relating to the extraction of Agarwood
from such trees through a process known as “inoculation.”
On September 30, 2018, the Company
and Mr. CHEN Zheru, representing the sole shareholder of IV Enterprises Development Limited, a Seychelles corporation (“IVED”),
entered into a Sale and Purchase Agreement, pursuant to which the Company acquired 100% (one hundred percent) of the shareholding of IVED.
IVED provides tree nurseries, including planting, cultivation and inoculation services through its wholly-owned subsidiary, Oudh Tech
Sdn Bhd, in Malaysia. The acquisition was completed on September 30, 2018.
Mr. CHEN Zheru was the common director
and major shareholder of the Company and IVED. As a result of this common ownership and in accordance with the FASB Accounting Standards
Codification Section 805 “Business Combination”, the transaction was treated as a combination between entities
under common control. The recognized assets and liabilities were transferred at their carrying amounts at the date of the transaction.
The equity accounts of the combining entities are combined. Further, the companies were combined retrospectively for prior year comparative
information as if the transaction had occurred on January 1, 2017.
On March 30, 2021, the Company and
Mr. Li Gongming (“Mr. Li”), the director of the Company, signed an instrument of transfer, pursuant to which Mr. Li acquired
100% (one hundred percent) of the shareholding of IVED. The consideration was set at $1, same as the consideration that the Company acquired
IVED in 2018. There was a gain of $65,154 on disposal of the subsidiaries due to an equity deficit of the disposed subsidiaries.
Our Board of Directors, Li Gongming, Teoh Kooi Sooi and
Soh Khay Wee resigned from the board of directors on April 7, 2021. On the same day, Teoh Kooi Sooi resigned from the roles of Chief Executive
Officer, Chief Financial Officer and Treasurer of the Company, David Edwin Evans resigned from the role of Chief Operation Officer of
the Company, Liao Lin resigned from the role of Chief Sales Officer of the Company, Jaya C Rajamanickam resigned from the role of President
of the Company while Feliana Binti Johny resigned from the role of Secretary of the Company.
On April 7, 2021, Mr. Gary Bartholomew was appointed as
the Director, Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer of the Company.
On April 22, 2021, CyberNorth Ventures
Inc. acquired an aggregate of 109,423,767 shares of Common Stock of the Company, representing approximately 77.6% of the issued and outstanding
shares of Common Stock of the Company as of such date, from the previous majority shareholders of the Company. As a result of such acquisition
CyberNorth Ventures Inc. is able to unilaterally control the election of our board of directors, all matters upon which shareholder approval
is required and, ultimately, the direction of our Company. CyberNorth Ventures Inc. is wholly owned by our director, Gary Bartholomew.
The Company does not currently have
operations.
3.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
Basis of presentation
The accompanying financial statements
are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).
The accompanying financial statements
include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions and balances were eliminated in consolidation.
As of June 30, 2021, there was no subsidiary held by the Company.
Use of estimates
Management uses estimates and assumptions
in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets
and liabilities, the disclosure of contingent assets and liabilities in the balance sheet, and the reported revenue and expenses during
the periods reported. Actual results may differ from these estimates.
Going Concern
The accompanying financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments
in the normal course of business. During the six months ended June 30, 2021, the Company incurred a loss before income tax of $19,021
and used cash in operations of $6,851. These factors raise substantial doubt about the Company’s ability to continue as a going
concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered
public accounting firm, in its report on the Company’s December 31, 2020 financial statements, has expressed substantial doubt about
the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary
if the Company is unable to continue as a going concern.
The Company’s ability to continue
as a going concern is dependent upon improving its profitability and the continuing financial support from its shareholders. Management
believes the existing shareholders or external financing will provide the additional cash to meet the Company’s obligations as they
become due. Despite the amount of funds that we have raised, no assurance can be given that any future financing, if needed, will be available
or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing,
if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders,
in the case of equity financing.
Cash and cash equivalents
Cash and cash equivalents are carried
at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments
with an original maturity of three months or less as of the purchase date of such investments.
Fair value of financial instruments
The carrying value of the Company’s
financial instruments: cash and cash equivalents, prepayments, amount due to a director and accrued liabilities approximate at their fair
values because of the short-term nature of these financial instruments.
The Company follows the guidance of
the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets
and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs
used in measuring fair value as follows:
|
·
|
Level 1 : Observable inputs such as quoted prices in active markets;
|
|
·
|
Level 2 : Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
|
|
·
|
Level 3 : Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions information regarding the impact of the adoption of ASC 842 on the Company’s financial statements.
|
Recent accounting pronouncements
In November 2016, the FASB issued Accounting
Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (ASU 2016-18), which requires companies to include
amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period
and end-of-period total amounts shown on the statement of cash flows. We adopted the new standard effective January 1, 2018, and the standard
did not have a material impact on our financial statements.
In January 2017, the FASB issued Accounting
Standards Update No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business (ASU 2017-01), which revises
the definition of a business and provides new guidance in evaluating when a set of transferred assets and activities is a business. We
adopted the new standard effective January 1, 2018 on a prospective basis. The new standard did not have a material impact on our consolidated
financial statements.
The Company has reviewed all recently
issued, but not yet effective, accounting pronouncements and do not believe the future adoption of any such pronouncements may be expected
to cause a material impact on its financial condition or the results of its operations.
4.
|
PREPAID EXPENSES AND OTHER RECEIVABLES
|
The prepaid expenses as of June 30,
2021 included OTCQB annual fee of $10,500, deposit of $100 in transfer agent, and $75,602 in other receivables from our former subsidiaries,
while the prepaid expenses as of December 31, 2020 included OTCQB annual fee of $14,000, deposit of $600 and $6,410 in transfer agent
and our consultancy firm.
The accrued liabilities as of June
30, 2021 included the auditor’s fee of $6,500, EDGAR fee of $1,025, professional fee to our consultancy firm of $24,359 and $2,569
payable to our former subsidiary, while the accrued liabilities as of December 31, 2020 included the auditor’s fee of $4,750, predecessor
auditor consent fee of $5,000 and professional fee to our consulting service provider of $19,231.
6.
|
AMOUNT DUE TO DIRECTOR
|
As of June 30, 2021, and December 31,
2020, our directors has loaned to the Company $59,744 and $49,744 as working capital, respectively. This loan is unsecured, non-interest
bearing and due on demand.
As of June 30, 2021, and December 31,
2020, there were 141,990,387 and 141,990,387 shares of common stock issued and outstanding respectively.
There were no stock options, warrants
or other potentially dilutive securities outstanding as of June 30, 2021.
8.
|
DISCONTINUED OPERATIONS
|
On March 30, 2021, the Company has
signed an instrument of transfer with our director, Mr. Li Gongming. Beginning on January 1, 2020, the Company historical financial results
for periods prior to the above transaction have been reflected in our statement of income, retrospectively, as discontinued operations.
Additionally, the related assets and liabilities associated with the discontinued operations in the prior year balance sheet are classified
as discontinued operations. As such, as of June 30, 2021, the Company accounted for all of its assets, liabilities and results of operations
up to June 30, 2021 as discontinued operations.
During the three months ended June
30, 2021, the Company did not record a gain or loss on this disposal of subsidiaries.
The following table shows the results
of operations of the Company for three months ended June 30, 2021 and 2020 which are included in the loss from discontinued operations:
Schedule of discontinued operations
|
|
Six months ended
June 30, 2021
|
|
|
Six months ended
June 30, 2020
|
|
|
|
|
|
|
|
|
REVENUE
|
|
$
|
–
|
|
|
$
|
–
|
|
COST OF REVENUE
|
|
|
–
|
|
|
|
–
|
|
GROSS PROFIT
|
|
|
–
|
|
|
|
–
|
|
GENERAL AND ADMINISTRATIVE EXPENSES
|
|
|
(8,062
|
)
|
|
|
–
|
|
LOSS FROM OPERATIONS
|
|
|
(8,062
|
)
|
|
|
–
|
|
OTHER INCOME/(EXPENSES)
|
|
|
–
|
|
|
|
–
|
|
LOSS BEFORE INCOME TAX
|
|
|
(8,062
|
)
|
|
|
–
|
|
INCOME TAX REFUND / (EXPENSE)
|
|
|
–
|
|
|
|
–
|
|
NET LOSS
|
|
$
|
(8,062
|
)
|
|
$
|
–
|
|
The following table shows the carrying
amounts of the major classes of assets and liabilities associated with the Company as of June 30, 2021:
Schedule of discontinued operations - balance sheet
|
|
As of
June 30, 2021
|
|
|
|
(Unaudited)
|
|
ASSETS
|
|
|
|
|
Current Assets
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
9,879
|
|
Prepaid expenses
|
|
|
86,202
|
|
Total Current Assets
|
|
|
96,081
|
|
Non-current Assets
|
|
|
|
|
Plant and equipment, net
|
|
|
–
|
|
Biological Assets
|
|
|
–
|
|
TOTAL ASSETS
|
|
$
|
96,081
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
Current Liabilities
|
|
|
|
|
Amount due to director
|
|
$
|
59,744
|
|
Amount due to former parent company
|
|
|
–
|
|
Accounts payable and accrued expenses
|
|
|
34,453
|
|
Total Current Liabilities
|
|
|
94,197
|
|
TOTAL LIABILITIES
|
|
$
|
94,197
|
|
|
|
|
|
|
STOCKHOLDERS’ EQUITY
|
|
|
|
|
Equity
|
|
|
1,884
|
|
TOTAL STOCKHOLDERS' EQUITY
|
|
|
1,884
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
96,081
|
|
On September 3, 2021, the Company’s
sole director and shareholder holding a majority of the Company’s voting stock approved the following actions by written consent:
change of the Company’s name to TrueNorth Quantum, Inc., designation of one share of Series A Preferred Stock with special voting
rights, and approval of a stock incentive plan and deferred stock unit plan.